3 Magnificent Stocks That Could Double or More by 2030 | The Motley Fool

Retrieved on: 2024-04-13 18:09:48

Tags for this article:

Biotechnology

Genetic engineering

Eli Lilly and Company

CRISPR

Gene therapy

Donanemab

Vertex Pharmaceuticals

Eli Lilly

Click the tags to see associated articles and topics

3 Magnificent Stocks That Could Double or More by 2030 | The Motley Fool. View article details on HISWAI: https://www.fool.com/investing/2024/04/13/magnificent-stocks-could-double-or-more-by-2030/

Summary

The article discusses the potential of stocks from CRISPR Therapeutics, Eli Lilly, and Viking Therapeutics to double by 2030, emphasizing their advancements in biotechnology and neuroscience. It highlights CRISPR's gene-editing technique and Eli Lilly's treatments, including for Alzheimer's, as key growth drivers.

Article found on: www.fool.com

View Original Article